Is bortezomib superior to high-dose dexamethasone for the treatment of relapsed multiple myeloma?
Orlowski
Robert Z
RZ
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599-7295, USA. r_orlowski@med.unc.edu